Hop-on, Inc. (HPNN) 股价，以美元计价

Hop-on, Inc. (HPNN.PK) Since 2003, the Company has continually obtained essential patent portfolio license agreements for mobile communications, computing and home entertainment devices. Hop-on is one of a few ODMs with a license with Nokia and Microsoft for their patent portfolio related to Android Operating Systems (link: http://news.microsoft.com/2014/02/20/hoponpr/) Hop-on's license agreements are poised to add 5G & next generation networks to microcells, MBMS to security innovations that will capitalize on global trends and will create a more effective pricing model business for 5G / 4G / LTE, Antennas, Connectivity, IoT, M2M, Small Cells. Hop-on's wholly subsidiary, Re-Medical, Inc., mission is to provide solutions for patients desiring to use cannabis as a nutraceutical alternative to traditional or prescription medications. Re-Medical is focused on alternative ways to deliver vitamins, supplements and other healthful products such as cannabis, utilizing transdermal patches and other novel technologies. The Re-Medical has developed and isolated the benefits of cannabis and other vital plant extracts for best patient care. There are an estimated 80+ cannabinoids found in cannabis, each providing distinctive neuropathic effects. The Re-Medical is currently applying for patents regarding the delivery of cannabis via transdermal patches. Re-Medical patches offer cost effective, accurate and clean delivery of these unique compounds.